These Four Biotech Stocks Are Trading With Massive Volume Today

NEW YORK, NY / ACCESSWIRE / April 19, 2016 / The Stock Expert is issuing a report on four stocks that are trading with heavier than usual volume. SGYP, RPRX, CPXX and HRTX are on high volume alert. Continue reading to find out why. – To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) Is a a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases.

Shares of SGYP are trading higher this morning by over 7% off massive volume this morning after announcing acceptance of a new drug application for Placanatide, a novel uroguanylin analog, in chronic idiopathic constipation.

Placanatide still has a long road to travel before production, however, this is a great early step for the drug candidate.

Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.

Repros Therapeutics Inc. (NASDAQ: RPRX) The company is a biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders for male and female in the United States.

RPRX was the recipient of a massive increase in volume last week and responded positively to the move.

Shares of RPRX are up over 200% in April after the injection of volume last week. We are watching to see if volume levels can stay high, pushing this one higher.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) Is a clinical stage biopharmaceutical company, develops therapies to treat cancer.

CPXX is trading slightly down this morning by 1%, however, the company has recently been performing extremely well after a massive injection of volume in mid-March.

The stock has been on a steady increase higher almost everyday in April and has comfortably traded higher even while the stock continues to be in oversold RSI (relative strength index) levels of 76.32.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

Heron Therapeutics, Inc. (NASDAQ: HRTX) The company focuses on developing novel, patient-focused solutions that apply their innovative science and technologies to already-approved pharmacological agents.

HRTX is trading higher today off much heavier than usual volume already eclipsing its average 3 day volume of 720,000.

Shares of HRTX are up by 8% early this morning and are looking good to hold these gains moving forward today.

The last 5 days for HRTX have looked excellent and we look forward to seeing if this company can continue moving higher.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About TheStockExpert.com

The Stock Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “STOCKEXPERT”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The Stock Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The Stock Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit TheStockExpert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The Stock Expert
info@thestockexpert.com

SOURCE: The Stock Expert

ReleaseID: 438989